Clinical Study
Plasma Plasminogen Activator Inhibitor-1 Is Associated with End-Stage Proliferative Diabetic Retinopathy in the Northern Chinese Han Population
Table 2
Univariate analysis of the progress of PDR.
| ā | OR | value | 95% CI |
| SBP | 1.027 | 0.007 | 1.007 | 1.047 | DBP | 1.034 | 0.031 | 1.003 | 1.065 | Duration of diabetes | 1.914 | | 1.872 | 1.957 | Family history of DM | 7.446 | | 3.701 | 14.982 | PAI-1 | 1.607 | | 1.329 | 1.942 | FBG | 0.869 | 0.017 | 0.775 | 0.975 | PBG | 0.948 | 0.115 | 0.888 | 1.013 | TC | 0 .932 | 0.588 | 0.723 | 1.202 | TG | 1.118 | 0.172 | 0.953 | 1.312 | CREA | 0.993 | 0.019 | 0.987 | 0.999 | BUN | 1.079 | 0.129 | 0.978 | 1.191 | Urine albumin | 0.734 | 0.004 | 0.594 | 0.907 | WBC | 1.068 | 0.406 | 0.914 | 1.249 | REC | 1.014 | 0.961 | 0.569 | 1.808 | MPV | 0.650 | 0.008 | 0.473 | 0.894 | History of hypertension | 0.933 | 0.802 | 0.545 | 1.600 | Smoking | 1.298 | 0.073 | 1.291 | 1.305 |
|
|